Military use of antipsychotics headache for pharma, trauma might be the only problem - not "mental illness" and Pfizer to pay $142.1 M: Monday news and blogs
More news: Military Use of Antipsychotics Threatens New Headaches for AstraZeneca, J | BNET Pharma Blog | BNET — AstraZeneca (AZ) and Johnson & Johnson (JNJ) can expect a fresh round of PR headaches from a brewing Senate inquiry into military personnel taking antipsychotic and antidepressant drugs for post-traumatic stress disorder associated with combat in... Continue Reading →
Monica Cassani
